NO304307B1 - Perfluoralkylsubstituerte benzoylguanidiner, deres anvendelse for fremstilling av medikamenter eller diagnostika, samt medikament inneholdende forbindelsen - Google Patents
Perfluoralkylsubstituerte benzoylguanidiner, deres anvendelse for fremstilling av medikamenter eller diagnostika, samt medikament inneholdende forbindelsenInfo
- Publication number
- NO304307B1 NO304307B1 NO951891A NO951891A NO304307B1 NO 304307 B1 NO304307 B1 NO 304307B1 NO 951891 A NO951891 A NO 951891A NO 951891 A NO951891 A NO 951891A NO 304307 B1 NO304307 B1 NO 304307B1
- Authority
- NO
- Norway
- Prior art keywords
- drugs
- perfluoroalkyl
- diagnostics
- manufacture
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4417004A DE4417004A1 (de) | 1994-05-13 | 1994-05-13 | Perfluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (3)
Publication Number | Publication Date |
---|---|
NO951891D0 NO951891D0 (no) | 1995-05-12 |
NO951891L NO951891L (no) | 1995-11-14 |
NO304307B1 true NO304307B1 (no) | 1998-11-30 |
Family
ID=6518126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO951891A NO304307B1 (no) | 1994-05-13 | 1995-05-12 | Perfluoralkylsubstituerte benzoylguanidiner, deres anvendelse for fremstilling av medikamenter eller diagnostika, samt medikament inneholdende forbindelsen |
Country Status (17)
Country | Link |
---|---|
US (1) | US5571842A (xx) |
EP (1) | EP0686627B1 (xx) |
JP (1) | JP3802582B2 (xx) |
KR (1) | KR100376194B1 (xx) |
CN (1) | CN1054373C (xx) |
AT (1) | ATE169903T1 (xx) |
AU (1) | AU687521B2 (xx) |
CA (1) | CA2149285C (xx) |
DE (2) | DE4417004A1 (xx) |
DK (1) | DK0686627T3 (xx) |
ES (1) | ES2121256T3 (xx) |
FI (1) | FI952290A (xx) |
HU (1) | HU223537B1 (xx) |
IL (1) | IL113688A (xx) |
NO (1) | NO304307B1 (xx) |
NZ (1) | NZ272103A (xx) |
TW (1) | TW418185B (xx) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4412334A1 (de) * | 1994-04-11 | 1995-10-19 | Hoechst Ag | Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4430916A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Alkyl-benzoylguanidin-Derivate |
DE19517848A1 (de) * | 1995-05-16 | 1996-11-21 | Merck Patent Gmbh | Fluorhaltige Benzoylguanidine |
US5994336A (en) * | 1995-06-07 | 1999-11-30 | Magainin Pharmaceuticals Inc. | Method of inhibiting proliferation of cells by administering an aminosterol compound |
US5847172A (en) * | 1995-06-07 | 1998-12-08 | Magainin Pharmaceuticals Inc. | Certain aminosterol compounds and pharmaceutical compositions including these compounds |
DE19531138A1 (de) * | 1995-08-24 | 1997-02-27 | Merck Patent Gmbh | Alkenyl-benzoylguanidin-Derivate |
EP0765867A1 (de) * | 1995-09-27 | 1997-04-02 | Hoechst Aktiengesellschaft | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament |
DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19542306A1 (de) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
PL316439A1 (en) * | 1995-11-20 | 1997-05-26 | Hoechst Ag | Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such |
DE19546736A1 (de) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate |
DE19608161A1 (de) | 1996-03-04 | 1997-09-11 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19621319A1 (de) * | 1996-05-28 | 1997-12-04 | Hoechst Ag | Bis-ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
EP2332580A1 (en) * | 1998-12-23 | 2011-06-15 | NeuroTherapeutics Pharma, Inc. | A composition for the treatment of the central nervous system |
US8722668B2 (en) * | 1998-12-23 | 2014-05-13 | Daryl W. Hochman | Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders |
US8008283B2 (en) * | 1998-12-23 | 2011-08-30 | Neurotherapeutics Pharma, Inc. | Methods and compositions for the treatment of neuropsychiatric disorders |
US6495601B1 (en) | 1998-12-23 | 2002-12-17 | Cytoscan Sciences Llc | Methods and compositions for treating conditions of the central and peripheral nervous systems using non-synaptic mechanisms |
US20060025387A1 (en) * | 1998-12-23 | 2006-02-02 | Cytoscan Sciences Llc | Compositions and methods for the treatment of disorders of the central and peripheral nervous systems |
US7214711B2 (en) * | 1998-12-23 | 2007-05-08 | Neurotherapeutics Pharma Llc | Method of treating migraine headache without aura |
DE10222192A1 (de) * | 2002-05-18 | 2003-11-27 | Aventis Pharma Gmbh | Pentafluorsulfuranyl-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
US7375138B2 (en) * | 2002-05-18 | 2008-05-20 | Sanofi-Aventis Deutschland Gmbh | Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them |
DE10226462A1 (de) * | 2002-06-13 | 2003-12-24 | Aventis Pharma Gmbh | Fluorierte Cycloalkyl-derivatisierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
US6878748B2 (en) * | 2002-06-13 | 2005-04-12 | Aventis Pharma Deutschland Gmbh | Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them |
DE10338554A1 (de) * | 2003-08-22 | 2005-03-31 | Aventis Pharma Deutschland Gmbh | Pentafluorosulfanylphenyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
US7381841B2 (en) * | 2003-08-22 | 2008-06-03 | Sanofi-Aventis Deutschland Gmbh | Pentafluorosulfanylphenyl-substituted benzoylguanidines, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
US20050124666A1 (en) * | 2003-11-13 | 2005-06-09 | Aventis Pharma Deutschland Gmbh | Pentafluorosulfanylbenzoylguanidines, process for their preparation, use as a medicament or diagnostic aid, and medicament comprising same |
DE10353204A1 (de) * | 2003-11-13 | 2005-06-16 | Aventis Pharma Deutschland Gmbh | Verfahren zur Herstellung von 4-Pentafluorsulfanyl-benzoylguanidinen |
OA13285A (en) | 2003-11-13 | 2007-01-31 | Sanofi Aventis Deutschland | Pentafluorosulfanyl benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing the same. |
EP1951702A2 (en) * | 2005-10-17 | 2008-08-06 | NeuroTherapeutics Pharma, Inc. | Diuretic-like compound analogs useful for regulation of central nervous system disorders |
KR200484534Y1 (ko) | 2017-07-18 | 2017-09-20 | 김경학 | 조립식 베개 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3780027A (en) * | 1970-04-29 | 1973-12-18 | Merck & Co Inc | Anthranilic acid derivatives |
DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
DK0556673T3 (da) * | 1992-02-15 | 1998-04-14 | Hoechst Ag | o-Substituerede benzoylguanidiner til behandling og profylakse af hjerterytmeforstyrrelser og iskæmisk inducerede skader samt til inhiberering af celleproliferation |
ATE139526T1 (de) * | 1992-02-15 | 1996-07-15 | Hoechst Ag | 3,5-substituierte benzoylguanidine, mit antiarrythmischer wirkung und inhibierender wirkung auf die proliferationen von zellen |
DK0577024T3 (xx) * | 1992-07-01 | 1997-02-24 | Hoechst Ag | |
TW250477B (xx) * | 1992-12-15 | 1995-07-01 | Hoechst Ag | |
DE4318658A1 (de) * | 1993-06-04 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1994
- 1994-05-13 DE DE4417004A patent/DE4417004A1/de not_active Withdrawn
-
1995
- 1995-04-07 TW TW084103534A patent/TW418185B/zh not_active IP Right Cessation
- 1995-05-08 AT AT95106922T patent/ATE169903T1/de not_active IP Right Cessation
- 1995-05-08 ES ES95106922T patent/ES2121256T3/es not_active Expired - Lifetime
- 1995-05-08 DE DE59503234T patent/DE59503234D1/de not_active Expired - Lifetime
- 1995-05-08 EP EP95106922A patent/EP0686627B1/de not_active Expired - Lifetime
- 1995-05-08 DK DK95106922T patent/DK0686627T3/da active
- 1995-05-11 CN CN95105374A patent/CN1054373C/zh not_active Expired - Fee Related
- 1995-05-11 NZ NZ272103A patent/NZ272103A/en unknown
- 1995-05-11 IL IL11368895A patent/IL113688A/xx not_active IP Right Cessation
- 1995-05-11 US US08/438,795 patent/US5571842A/en not_active Expired - Lifetime
- 1995-05-11 FI FI952290A patent/FI952290A/fi unknown
- 1995-05-11 AU AU17999/95A patent/AU687521B2/en not_active Ceased
- 1995-05-12 KR KR1019950011652A patent/KR100376194B1/ko not_active IP Right Cessation
- 1995-05-12 CA CA002149285A patent/CA2149285C/en not_active Expired - Fee Related
- 1995-05-12 HU HU9501407A patent/HU223537B1/hu not_active IP Right Cessation
- 1995-05-12 JP JP11418895A patent/JP3802582B2/ja not_active Expired - Fee Related
- 1995-05-12 NO NO951891A patent/NO304307B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL113688A0 (en) | 1995-08-31 |
EP0686627A3 (de) | 1996-01-31 |
EP0686627A2 (de) | 1995-12-13 |
HUT71800A (en) | 1996-02-28 |
CA2149285A1 (en) | 1995-11-14 |
AU1799995A (en) | 1995-11-23 |
FI952290A0 (fi) | 1995-05-11 |
DE59503234D1 (de) | 1998-09-24 |
KR100376194B1 (ko) | 2003-05-17 |
HU9501407D0 (en) | 1995-06-28 |
JP3802582B2 (ja) | 2006-07-26 |
KR950032098A (ko) | 1995-12-20 |
HU223537B1 (hu) | 2004-08-30 |
EP0686627B1 (de) | 1998-08-19 |
NZ272103A (en) | 1996-10-28 |
ES2121256T3 (es) | 1998-11-16 |
DK0686627T3 (da) | 1999-05-25 |
US5571842A (en) | 1996-11-05 |
CN1054373C (zh) | 2000-07-12 |
JPH07304729A (ja) | 1995-11-21 |
TW418185B (en) | 2001-01-11 |
ATE169903T1 (de) | 1998-09-15 |
FI952290A (fi) | 1995-11-14 |
CA2149285C (en) | 2007-09-18 |
CN1126201A (zh) | 1996-07-10 |
NO951891L (no) | 1995-11-14 |
AU687521B2 (en) | 1998-02-26 |
NO951891D0 (no) | 1995-05-12 |
IL113688A (en) | 1999-06-20 |
DE4417004A1 (de) | 1995-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO304307B1 (no) | Perfluoralkylsubstituerte benzoylguanidiner, deres anvendelse for fremstilling av medikamenter eller diagnostika, samt medikament inneholdende forbindelsen | |
BR9407832A (pt) | Fenilsulfoniluréias processo para sua preparação e seu uso como herbicida e reguladores de crescimento de plantas | |
FI953003A (fi) | Perfluorialkyyliryhmillä varustettuja fenyylisubstituoituja alkenyylikarboksyylihappoguanididejä, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine | |
SE8204347L (sv) | N-fenylpyrazolderivat anvendbara som herbicider | |
BR9911416A (pt) | Absorvedores de luz ultravioleta de carbamato de poli-trisaril-1,3,5-triazina | |
DE3584393D1 (de) | 1-heteroaryl-4-aryl-pyrozolin-5-one. | |
SE8600017L (sv) | Ny forening | |
DE59204456D1 (de) | Substituierte N-Phenylpiperidine und Arzneimittel daraus. | |
NO872409L (no) | Substituerte 4-benzylpiperazinyl-forbindelser. | |
NO302231B1 (no) | Fenylsubstituerte alkylkarboksylsyreguanidider som bærer perfluoralkylgrupper, deres anvendelse til fremstilling av medikament eller diagnostikum samt medikamenter inneholdende disse | |
EP0481299A3 (en) | N-phenyl-piperidyl-4-amines and drugs containing them | |
ATE27452T1 (de) | Substituierte o-phenylendiaminderivate. | |
FI853082L (fi) | Syntetisk polypeptid, som motsvarar escherichia coli's vaermelabila enterotoxins del, samt kompositioner och foerfaranden i vilka denna aer anvaend. | |
ATE157539T1 (de) | 3-benzoyl-3,7-diazabicyclo(3,3,1)nonan- verbindungen mit anti-arrhythmischer wirkung | |
DE3774942D1 (de) | Neue tetrahydro-benzothiazole, ihre herstellung und verwendung. | |
NO306991B1 (no) | Alkenylbenzoylguanidinderivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler | |
ATE205834T1 (de) | 1,6-dihydro-6-oxo-3-pyridazinyloxy- benzoylguanidin-derivate, deren herstellung und deren verwendung als inhibitoren des zellulären na+/h+-antiporters | |
BE811324A (en) | Amino alkyl 2,6-dialkyl-4-aryl-1,4 dihydropyridine-3, carboxylates - useful as cerebral vasodilators and musculotropic spasmolytic agents | |
PE50296A1 (es) | Eter substituido con tiazol y oxazol biciclico | |
FR2218107A1 (en) | Amino alkyl 2,6-dialkyl-4-aryl-1,4 dihydropyridine-3, carboxylates - useful as cerebral vasodilators and musculotropic spasmolytic agents | |
DE69013476D1 (de) | Anwendung von Naphthoxazinen. | |
ATE171173T1 (de) | 5-tetrahydropyranon-cyclohexenonoximether und deren verwendung als herbizide | |
FR2342729A1 (fr) | Nouveaux derives de la carbamoyloxymethyl-5 oxazolidinone-2, leur procede de preparation et leur application en therapeutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |